Name | EGFR-IN-21 |
---|
Description | EGFR-IN-21 is a potent EGFR inhibtior with an IC50 of 0.38 nM. EGFR-IN-21 has antitumor activity[1]. |
---|---|
Related Catalog | |
Target |
EGFR:0.38 nM (IC50) |
In Vitro | EGFR-IN-21 inhibits HEK293T cells (IC50=951.51 nM) and PC9 EGFR-Del19/T790M/C797S cells (IC50=135.11 nM)[1]. |
In Vivo | EGFR-IN-21 (1 mg/kg; IV) has a T1/2 of 3.33 hours, and a Vss of 0.374 L/kg for female CD-1 mouse[1]. EGFR-IN-21 (5 mg/kg;po) has a T1/2 of 3.13 hours, a Cmax of 2077 ng/ml and an AUC of 7542 h·ng/ml[1]. |
References |
[1]. Lei Liu, et al. Polyaryl compounds as EGFR kinase inhibitors. WO2021104441. |
Molecular Formula | C36H44BrN10O2P |
---|---|
Molecular Weight | 759.68 |